Language:
Password reminder
No account yet? Register Free
About Us Advertising Info Contact Us Client Login
labmedica.com
Microbiology
Features Subscription Partner Sites Journal Info
RANDOX LABORATORIESNUAIRE, INC.           AB SCIEX

POCTs Urgently Needed in Resource-Limited Countries

By Labmedica International staff writers
Posted on 20 Jun 2012


In resource-limited settings, the impact of diagnostic tests that can be provided at the immediate point-of-care (a point-of-care test or POCT) is potentially even greater, because the alternative to a POCT may be no diagnostic support at all.

Easy-to-use, inexpensive tests to diagnose infectious diseases are urgently needed in resource-limited settings. A new report based on an American Academy of Microbiology colloquium (September, 2011; Washington DC, USA), describes the challenges inherent in bringing new medical devices and technologies to the areas of the world where they are needed most.

Point-of-care diagnostics (POCTs) bypass the need for sophisticated laboratory systems by leveraging new technologies to diagnose infectious diseases and other health concerns at the bedside, or point-of-care. Diagnostics account for 2% of the cost of health care, yet can affect 60%-70% of treatment decisions. In resource limited areas where advanced laboratory services are not available, access to POCTs may be the difference between making a treatment decision that is informed by an accurate diagnosis versus one that is ineffective or even harmful.

Despite the urgent need for POCTs, deploying them in resource-limited settings can be difficult. "POCTs are developed by researchers and engineers and implemented by a separate group of public health professionals at a local level. There are so many variables that can make or break the effectiveness of any test, and so often the scientists and engineers developing the test are not aware of them." said Keith Klugman, who chaired the colloquium. "POCTs that perform well in testing may not function 'on the ground' in resource-limited areas, where there may not be running water, electricity, or trained personnel to administer the test."

Recognizing the need to connect the scientists and engineers developing the POCTs with the health care workers implementing them, the American Academy of Microbiology convened the colloquium to discuss how to develop POCTs that can be effectively integrated into resource-limited settings. The participants discussed which tests were needed most urgently, features that should be incorporated in the design of the test to make it more effective in the field, and how collaborations between communities could foster an environment of success for new POCTs.

The resulting report makes recommendations in several areas. It details a list of POCTs that would make the biggest impact, for example, tests to detect drug resistance, or effectively monitor viral load in HIV patients. The report describes qualities needed such as minimal power requirements, simple interfaces, and integrated instructions on use and quality control protocols. Finally, it recommends changes in how POCTs are regulated, approved, and brought to market to help foster a more conducive environment for POCT development.

Related Links:

American Academy of Microbiology






CHEMISTRY ANALYZER
CHEMISTRY ANALYZER
Automimmune Disease Marker
Automimmune Disease Marker
Colorectal Cancer Test
Colorectal Cancer Test

More Products

Latest Microbiology News

LinkXpress
Click for LinkXpress
Reader Inquiry Service
Enter code to receive information:
Where I can find code?
Featured Whitepaper
SIEMENS DIAGNOSTICS :
Siemens Healthcare Diagnostics Anti-CCP: A Clinical Evaluation Whitepaper

Download Whitepaper
Events
EuroMedLab 2013 - 20th IFCC-EFCC European Congress of Clinical Chemistry and Laboratory Medicine
19 May 2013 - 23 May 2013


ELA – European Lab Automation congress
06 Jun 2013 - 07 Jun 2013


European Human Genetics Conference 2013
08 Jun 2013 - 11 Jun 2013


More events
GLOBETECH PUBLISHING
Latest Issue

View Digital Edition
Subscribe / Renew
77 ELEKTRONIKA
BioPorto Diagnostics
GREINER-BIO-ONE
ALTO MARKETING LIMITED
AACC
KARL HECHT GMBH & CO KG
DIASOURCE
  labmedica.com Copyright © 2000-2013 Globetech Media. All rights reserved.
Privacy Policy